Early-Stage trial tests drug to tame gluten reaction
NCT ID NCT05574010
Summary
This study tested an investigational drug, KAN-101, to see if it could help control the immune system's harmful reaction to gluten in people with celiac disease. Researchers enrolled 128 adults already on a gluten-free diet to test the drug's safety and its effect on a key immune marker. The trial was terminated early, and its results for helping patients manage the disease are not yet known.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CELIAC DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Advanced Research Institute
Ogden, Utah, 84405, United States
-
Agile Clinical Research Trials
Sandy Springs, Georgia, 30328, United States
-
Anaheim Clinical Trials, LLC
Anaheim, California, 92801, United States
-
Aventiv Research, Inc. d/b/a Centricity Research
Columbus, Ohio, 43213, United States
-
Box Hill Hospital
Box Hill, Victoria, 3128, Australia
-
Campbelltown Hospital
Campbelltown, New South Wales, 2560, Australia
-
Celiac Disease Center at Columbia University
New York, New York, 10032, United States
-
Digestive Research of Central Texas
Waco, Texas, 76712, United States
-
GCP Research
St. Petersburg, Florida, 33705, United States
-
Great Lakes Gastroenterology Research, LLC
Mentor, Ohio, 44060, United States
-
Indiana University Health University Hospital
Indianapolis, Indiana, 46202, United States
-
Mayo Clinic
Rochester, Minnesota, 55905, United States
-
North Carolina Clinical Research
Raleigh, North Carolina, 27607, United States
-
Northshore Gastroenterology Research, LLC
Westlake, Ohio, 44145, United States
-
Optimal Clinical Trials
Auckland, Auckland, 1023, New Zealand
-
P3 Research - Dunedin
Dunedin, Otago, 9016, New Zealand
-
P3 Research - Palmerston North
Paraparaumu, Wellington Region, 5032, New Zealand
-
P3 Research - Tauranga
Tauranga, Bay of Plenty, 3110, New Zealand
-
P3 Research - Wellington
Wellington, Wellington Region, 6021, New Zealand
-
PCRN Trials
Takapuna, Auckland, 0622, New Zealand
-
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, 17033, United States
-
Prism Research LLC dba Nucleus Network
Saint Paul, Minnesota, 55114, United States
-
Quality Clinical Research
Omaha, Nebraska, 68114, United States
-
Royal Adelaide Hospital
Adelaide, South Australia, 5000, Australia
-
Rush University Medical Center
Chicago, Illinois, 60612, United States
-
Sneeze, Wheeze & Itch Associates, LLC
Normal, Illinois, 61761, United States
-
St John of God Midland Public and Private Hospitals
Midland, Western Australia, 6056, Australia
-
The Royal Melbourne Hospital
Parkville, Victoria, 3050, Australia
-
The University of Texas Health Science Center at Houston
Houston, Texas, 77030, United States
-
University of Alabama at Birmingham
Birmingham, Alabama, 35233, United States
-
University of Iowa
Iowa City, Iowa, 52242, United States
-
Vanderbilt University Medical Center
Nashville, Tennessee, 37212, United States
-
Velocity Clinical Research, Salt Lake City
West Jordan, Utah, 84088, United States
-
Waikato Hospital
Hamilton, Hamilton, 3204, New Zealand
-
Washington University School of Medicine
St Louis, Missouri, 63110, United States
-
Wesley Research Institute
Auchenflower, Queensland, 4066, Australia
Conditions
Explore the condition pages connected to this study.